July 24, 2016 4:00 PM ET


Company Overview of Regen BioPharma Inc.

Executive Profile

Thomas E. Ichim Ph.D.

Senior Research Consultant, Regen BioPharma Inc.
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 9 different industries.

See Board Relationships
As of Fiscal Year 2015


Dr. Thomas E. Ichim, Ph.D., also known as Tom, has been Senior Research Consultant at Regen BioPharma Inc since July 2, 2016. Dr. Ichim has been the President and Chief Scientific Officer at Medistem, Inc., since October 6, 2012. Dr. Ichim is a Co-founder of Batu Biologics, Inc. and has been its Chief Scientific Officer since December 21, 2015. Dr. Ichim is the founder of ToleroTech Inc., OncoMune LLC and MedVax Pharma Corp. He served as Director of Research and Chief ...

Corporate Headquarters

4700 Spring Street
La Mesa, California 91942

United States

Phone: 619-702-1404
Fax: 619-330-2328

Board Members Memberships

President, Chief Scientific Officer and Director
Senior Vice President, Director, Chief Executive Officer of Biotechnology Division and President of Biotechnology Division


BS 1998
University of Waterloo
MS 2003
The University Of Western Ontario

Other Affiliations

Annual Compensation

Total Annual Compensation$120,000

Stocks Options

Restricted Stock Awards$540,250

Total Compensation

Total Annual Cash Compensation$120,000
Total Short Term Compensation$120,000
Other Long Term Compensation$540,250
Total Calculated Compensation$660,250

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Regen BioPharma Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.